Lung Cancer Liver Cancer Pancreatic Cancer Esophageal Cancer Stomach Cancer
A key yardstick used to evaluate success in cancer treatment shows that for many cancers, a higher percentage of people diagnosed at the University of Colorado Cancer Center have survived five years or more beyond their diagnoses than for the nation as a whole.
Research Pancreatic Cancer Immunotherapy Surgery
Yuwen Zhu, PhD, grew up in a rural village in China. His mother couldn’t read. “I really didn’t know about college – even what the word meant,” he says.
University of Colorado Cancer Center member Sana Karam, MD, PhD, has received a translational research grant from the V Foundation for Cancer Research, co-founded by ESPN and legendary basketball coach Jim Valvano, to study a new therapeutic that may help pancreatic cancer patients overcome resistance to radiation therapy.
Research Pancreatic Cancer Surgical Oncology
Chemotherapy is a useful treatment to try to get systemic control in pancreatic cancer. Currently, however, chemotherapy is mostly administered in patients whose tumors are more difficult to remove surgically because of where they are in the anatomy.
Pancreatic Cancer Cancer Surgical Oncology Whipple procedure
It’s been just over four years since Jim Page entrusted his fate to a University of Colorado Cancer Center surgical oncologist after being diagnosed with precancerous cysts in his pancreas. Four years since he underwent the surgery that he credits with saving his life.
University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, division chief of surgical oncology, is coordinating a new effort to standardize global diagnosis and treatment efforts for cystic tumor of the pancreas. More frequent than solid lesions, cystic tumors are usually detected incidentally and are often asymptomatic.
Patient Care Community Pancreatic Cancer Multidisciplinary Clinic
Barb Spanjer lay on the floor of her office. She had never been so tired. Her stomach and left side ached, and the pain under her left shoulder blade was relentless. She had seen her doctor a couple of times that autumn of 2017, but the medicine for the ulcer he suspected she had wasn’t working. She had been too tired and too busy running the construction company she and her husband, Steve, owned to follow up with the doctor. But it was getting harder to ignore the symptoms. Something just wasn’t right.
Research Pancreatic Cancer Surgical Oncology Transplant Surgery
Intraductal papillary mucinous neoplasms (IPMNs) are cystic lesions that can form by the ducts of the pancreas. They generally are asymptomatic and discovered in the course of testing for other conditions.
Research Press Releases Pancreatic Cancer Clinical Trials
A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.
Patient Care Pancreatic Cancer Surgical Oncology Multidisciplinary Clinic
Before receiving a pancreatic cancer diagnosis eight years ago – a diagnosis that resulted from persistent self-advocacy – Carolyn Degrafinried spent one awful weekend wondering if she was losing her mind.
Education Pancreatic Cancer Surgical Oncology
When surgeons from the Netherlands needed help establishing a national program for patients with hard-to-treat pancreatic cancer, they knew just whom to turn to: Marco Del Chiaro, MD, PhD, professor and division chief of surgical oncology in the University of Colorado Department of Surgery.
Research Press Releases Pancreatic Cancer
Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.
Patient Care Awareness Pancreatic Cancer Surgical Oncology
Laura Foote is now three years out from her pancreatic cancer diagnosis, thanks to a surgery performed by Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center and chair of the Department of Surgery.
Research Faculty Pancreatic Cancer Pilot Award
Two research investigations being led by University of Colorado Cancer Center researchers are receiving grant support this year from Wings of Hope for Pancreatic Research.
Research Faculty Pancreatic Cancer Funding
Some battles begin before a shot is even fired, with an army building bridges and grading roads, clearing and smoothing the path to make the invading force stronger and more effective.
Research Faculty Pancreatic Cancer Surgical Oncology
Two University of Colorado Cancer Center physicians have been recognized as world experts in in pancreatic neoplasms by the 2021 Expertscape rankings.
Community Pancreatic Cancer Surgical Oncology
Actor Willie Garson was probably best known for his role as Stanford Blatch on “Sex and the City,” playing one of Carrie Bradshaw’s New York-savvy best friends.
Innovation Patient Care Pancreatic Cancer Surgical Oncology
After suffering from painful bouts of pancreatitis for more than a decade, Christina Gonzalez felt resigned to a seemingly endless cycle of procedures.
Patient Care Pancreatic Cancer Surgical Oncology
Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center, becomes close with all of his patients, but he has a special bond with Gerry Turner, one of Schulick’s surgical patients for pancreatic cancer.
A multiyear grant totaling $500,000 is aimed at making the University of Colorado Cancer Center even better at providing multidisciplinary care for patients with pancreatic cancer.
Awareness Pancreatic Cancer Magazine Surgical Oncology
Longtime “Jeopardy!” host Alex Trebek announced it to the world on March 6, 2019: Like 50,000 other Americans each year, he had been diagnosed with stage 4 pancreatic cancer.
Research Publications Pancreatic Cancer Surgical Oncology
In the 1860s, French physician Armand Trousseau noticed that patients with a certain form of abnormal blood clotting often went on to be diagnosed with pancreas or gastric cancers. Unfortunately, at age 66 he noticed these same symptoms in himself and died of gastric cancer only a few months later.
The most important factor predicting the survival of pancreatic cancer patients is whether the cancer can be surgically removed (whether the cancer is “resectable”). The answer isn’t always clear. Some centers may consider a tumor too entangled with neighboring organs and blood vessels for surgery to be an option, leading to the use of surgery in only about 15 to 20 percent of pancreatic cancers, nationally. Due in part to advanced surgical techniques, more effective medicines, and a multidisciplinary approach to treating the disease, University of Colorado Cancer Center is able to operate on 30 percent or more of pancreatic cancer patients, nearly double the national average.
Patient Care Pancreatic Cancer
I have been asked to share my story of being a very fortunate survivor of pancreatic cancer. At the time I am writing this I am one year out from my last treatment and have had all “clean” check-ups!
Research Faculty Pancreatic Cancer
A University of Colorado Cancer study published this week in the journal Carcinogenesis shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells’ energy source and eventually killing them.
Cure Today
July 12, 2024
University of Colorado Cancer Center member Dr. Steven Thorpe emphasizes the collaborative nature of treating soft tissue and bone sarcomas, highlighting the multidisciplinary efforts at CU School of Medicine's Department of Orthopedics and Children’s Hospital Colorado. He underscores the goal of not only curing the disease but also preserving function through advanced surgical techniques and modern therapies, ensuring patients maintain quality of life post-treatment. Thorpe stresses the importance of long-term outcomes, tailoring treatments to support patients’ aspirations beyond their cancer journey, especially for pediatric cases.
OncLive
July 08, 2024
CU Cancer Center member S. Lindsey Davis, MD, highlighted that the combination therapy of sapanisertib and alisertib showed marginal clinical benefit for patients with advanced solid tumors, correlative analyses suggested that apoptotic response and tumor immune cell infiltrate might influence clinical outcomes. The phase 1b study's expansion cohort indicated some positive outlying responses among patients and underscore the need for further research to tailor treatments for standout patients and explore rational combinations to enhance efficacy.
News Medical
June 19, 2024
A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.
Cancer Network
June 14, 2024
In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.
Mark Harden
